Education
About Us
Working with TipRanks
Follow Us
Vitrolife AB (GB:0YAY)
LSE:0YAY
0YAY Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr144.50 - kr265.80
Previous CloseN/A
Volume1.22K
Average Volume (3M)16.45K
Market Cap
kr20.57B
Enterprise Valuekr30.13B
Total Cash (Recent Filing)kr1.14B
Total Debt (Recent Filing)kr2.09B
Price to Earnings (P/E)39.1
Beta0.81
Next Earnings
Apr 24, 2025EPS Estimate
0.92Next Dividend Ex-Date
Apr 30, 2025Dividend Yield0.65%
Share Statistics
EPS (TTM)1.03
Shares Outstanding135,447,190
10 Day Avg. Volume10,555
30 Day Avg. Volume16,449
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.80%
Mutual Funds
― Other Institutional Investors
96.04% Public Companies and
Individual Investors
0YAY FAQ
What was Vitrolife AB’s price range in the past 12 months?
Vitrolife AB lowest share price was kr144.50 and its highest was kr265.80 in the past 12 months.
What is Vitrolife AB’s market cap?
Vitrolife AB’s market cap is kr20.57B.
When is Vitrolife AB’s upcoming earnings report date?
Vitrolife AB’s upcoming earnings report date is Apr 24, 2025 which is tomorrow.
How were Vitrolife AB’s earnings last quarter?
Vitrolife AB released its earnings results on Jan 30, 2025. The company reported kr1.03 earnings per share for the quarter, missing the consensus estimate of kr1.106 by -kr0.076.
Is Vitrolife AB overvalued?
According to Wall Street analysts Vitrolife AB’s price is currently Overvalued.
Does Vitrolife AB pay dividends?
Vitrolife AB pays a Annually dividend of kr1.1 which represents an annual dividend yield of 0.65%. See more information on Vitrolife AB dividends here
What is Vitrolife AB’s EPS estimate?
Vitrolife AB’s EPS estimate is 0.92.
How many shares outstanding does Vitrolife AB have?
Vitrolife AB has 135,447,190 shares outstanding.
What happened to Vitrolife AB’s price movement after its last earnings report?
Vitrolife AB reported an EPS of kr1.03 in its last earnings report, missing expectations of kr1.106. Following the earnings report the stock price went up 4.415%.
Which hedge fund is a major shareholder of Vitrolife AB?
Currently, no hedge funds are holding shares in GB:0YAY
---
Company Description
Vitrolife AB
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
---
0YAY Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Elekta AB
―
AddLife AB
―
BONESUPPORT HOLDING AB
―
Xvivo Perfusion AB
―
BioArctic AB Class B
―
---